BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31163210)

  • 1. M100907 and BD 1047 attenuate the acute toxic effects of methamphetamine.
    Ray A; Canal CE; Ehlen JC; Rice KC; Murnane KS
    Neurotoxicology; 2019 Sep; 74():91-99. PubMed ID: 31163210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute treatments with the serotonin 2A antagonist M100907 alone or in combination with the serotonin 2C agonist WAY163909 on methamphetamine self-administration in rhesus monkeys.
    Odabas-Geldiay M; Shields H; Berro LF; Rice KC; Howell LL
    Drug Alcohol Depend; 2019 Jan; 194():252-256. PubMed ID: 30469095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. σ Receptor antagonist attenuation of methamphetamine-induced neurotoxicity is correlated to body temperature modulation.
    Robson MJ; Seminerio MJ; McCurdy CR; Coop A; Matsumoto RR
    Pharmacol Rep; 2013; 65(2):343-9. PubMed ID: 23744418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CM156, a high affinity sigma ligand, attenuates the stimulant and neurotoxic effects of methamphetamine in mice.
    Kaushal N; Seminerio MJ; Shaikh J; Medina MA; Mesangeau C; Wilson LL; McCurdy CR; Matsumoto RR
    Neuropharmacology; 2011; 61(5-6):992-1000. PubMed ID: 21762711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological evaluation of SN79, a sigma (σ) receptor ligand, against methamphetamine-induced neurotoxicity in vivo.
    Kaushal N; Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):960-71. PubMed ID: 22921523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking serotonin 2A (5-HT
    Madden JT; Reyna NC; Goranson EV; Gonzalez TA; Zavala AR; Pentkowski NS
    Behav Brain Res; 2021 Oct; 415():113521. PubMed ID: 34391796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.
    Kitanaka J; Kitanaka N; Tatsuta T; Hall FS; Uhl GR; Tanaka K; Nishiyama N; Morita Y; Takemura M
    Psychopharmacology (Berl); 2009 May; 203(4):781-92. PubMed ID: 19052726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonizing serotonin 2A (5-HT
    Madden JT; Reyna NC; Pentkowski NS
    Drug Alcohol Depend; 2020 Oct; 215():108178. PubMed ID: 32739601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effects of alpha-phenyl-N-tert-butyl nitrone pretreatment on the neurobehavioral effects of methamphetamine.
    Kita T; Matsunari Y; Saraya T; Shimada K; O'Hara K; Kubo K; Wagner GC; Nakashima T
    Life Sci; 2000 Aug; 67(13):1559-71. PubMed ID: 10983851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SN79, a sigma receptor antagonist, attenuates methamphetamine-induced astrogliosis through a blockade of OSMR/gp130 signaling and STAT3 phosphorylation.
    Robson MJ; Turner RC; Naser ZJ; McCurdy CR; O'Callaghan JP; Huber JD; Matsumoto RR
    Exp Neurol; 2014 Apr; 254():180-9. PubMed ID: 24508558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice.
    Seminerio MJ; Kaushal N; Shaikh J; Huber JD; Coop A; Matsumoto RR
    Pharmacol Biochem Behav; 2011 Mar; 98(1):12-20. PubMed ID: 21130800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studies.
    Matsumoto RR; Shaikh J; Wilson LL; Vedam S; Coop A
    Eur Neuropsychopharmacol; 2008 Dec; 18(12):871-81. PubMed ID: 18755577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1β mRNA expression in the hypothalamus.
    Seminerio MJ; Robson MJ; McCurdy CR; Matsumoto RR
    Eur J Pharmacol; 2012 Sep; 691(1-3):103-9. PubMed ID: 22820108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
    Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
    J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nantenine: an antagonist of the behavioral and physiological effects of MDMA in mice.
    Fantegrossi WE; Kiessel CL; Leach PT; Van Martin C; Karabenick RL; Chen X; Ohizumi Y; Ullrich T; Rice KC; Woods JH
    Psychopharmacology (Berl); 2004 May; 173(3-4):270-7. PubMed ID: 14740148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of methylphenidate-, amphetamine-, and methamphetamine-induced hyperthermia and neurotoxicity in male Sprague-Dawley rats during the waking (lights off) cycle.
    Levi MS; Divine B; Hanig JP; Doerge DR; Vanlandingham MM; George NI; Twaddle NC; Bowyer JF
    Neurotoxicol Teratol; 2012 Mar; 34(2):253-62. PubMed ID: 22289608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT2A receptor antagonist M100907 reduces serotonin synthesis: an autoradiographic study.
    Hasegawa S; Fikre-Merid M; Diksic M
    Brain Res Bull; 2012 Jan; 87(1):44-9. PubMed ID: 22056993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonizing 5-HT₂A receptors with M100907 and stimulating 5-HT₂C receptors with Ro60-0175 blocks cocaine-induced locomotion and zif268 mRNA expression in Sprague-Dawley rats.
    Burton CL; Rizos Z; Diwan M; Nobrega JN; Fletcher PJ
    Behav Brain Res; 2013 Mar; 240():171-81. PubMed ID: 23201361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity of functionalizable derivatives of the serotonin (5-HT) 5-HT
    Gilbertson SR; Chen YC; Soto CA; Yang Y; Rice KC; Cunningham KA; Anastasio NC
    Bioorg Med Chem Lett; 2018 May; 28(8):1381-1385. PubMed ID: 29555153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sigma-1 receptor reduces N-methyl-D-aspartate induced neuronal injury in methamphetamine-exposed and -naive hippocampi.
    Smith KJ; Butler TR; Prendergast MA
    Neurosci Lett; 2010 Sep; 481(3):144-8. PubMed ID: 20600592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.